Paid Clinical Trials Alaska
Discover 99 paid clinical trials in Alaska. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
HEPA PurifiersThe Clean Air Study: HEPA Purifiers to Improve Indoor Air Quality and Health in Rural Alaska Homes
Sponsor:
Alaska Native Tribal Health Consortium
Location:
Code:
NCT06534385
Conditions
Air Pollution, Indoor
Eligibility Criteria
Sex: All
Age: 0 - 5
Healthy Volunteers: Accepted
Interventions
Air purifier
ZongertinibBeamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations
Sponsor:
Boehringer Ingelheim
Location:
Code:
NCT06581432
Conditions
Solid Tumours
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Zongertinib
Metabolism-Informed CareMetabolism-Informed Care to Aid Alaska Native People to Quit Smoking (QUIT)
Sponsor:
Southcentral Foundation
Location:
Code:
NCT06556238
Conditions
Smoking Cessation
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Nicotine Metabolite Ratio
Molecular Residual DiseaseEXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Sponsor:
Exact Sciences Corporation
Location:
Code:
NCT06401421
Conditions
Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
ctDNA MRD test
Observational StudySchool Screening and Telemedicine Specialty Referral to Address Childhood Hearing Loss in Rural Alaska
Sponsor:
University of Arkansas
Location:
Code:
NCT05593484
Conditions
Hearing Loss
Eligibility Criteria
Sex: All
Age: 3 - 21
Healthy Volunteers: Accepted
Interventions
Standard Referral
Specialty Telemedicine Access for Referrals (STAR)
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Golcadomide & RituximabA Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular Lymphoma
Sponsor:
Celgene
Location:
Code:
NCT06425302
Conditions
Lymphoma, Follicular
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Golcadomide
Rituximab
Cyclophosphamide
Doxorubicin
Vincristine
RAINBO BLUE & TAPERAdjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
Sponsor:
Canadian Cancer Trials Group
Location:
Code:
NCT05640999
Conditions
Endometrial Cancer
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Vaginal brachytherapy
Adjuvant radiotherapy (EBRT +/- brachytherapy)
Observation
Rina-S vs. Investigator's ChoiceStudy to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer
Sponsor:
Genmab
Location:
Code:
NCT06619236
Conditions
Platinum-resistant Ovarian Cancer
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Rina-S
Paclitaxel
Topotecan
Pegylated liposomal doxorubicin (PLD)
Gemcitabine
TelemedicineThe TELENEO Trial: a Multicenter Trial of Telemedicine for Advanced Neonatal Resuscitations in Community Hospitals
Sponsor:
Mayo Clinic
Location:
Code:
NCT06087224
Conditions
Death; Neonatal
Morbidity;Newborn
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
Interventions
Teleneonatology
Tailoring TherapyTailoring Therapy in Post-surgical Patients With Low-risk Endometrial Cancer
Sponsor:
NRG Oncology
Location:
Code:
NCT06388018
Conditions
Stage I Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
Stage II Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
Stage III Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Clinical Observation
Computed Tomography
External Beam Radiation Therapy
High-Dose-Rate Vaginal Brachytherapy
Magnetic Resonance Imaging